Tag Archives: Market Access
PBAC Meeting Outcomes – July 2018
The July 2018 PBAC Meeting Outcomes were published on 17th August 2018. With 64 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including additional analysis conducted on biosimilar and oncology submissions. … Continue reading
PBAC Special Meeting – August 2018
The August 2018 PBAC special meeting is scheduled for 17 August 2018 to consider options for listing PD-1 and PD-L1 checkpoint inhibitors for the treatment of multiple tumours (pan-tumour indications) on the PBS. Here, the Commercial Eyes Market Access team … Continue reading
The long road to PBS listing for Orkambi
Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading
PBAC Meeting Agenda – July 2018
The July 2018 PBAC Meeting is scheduled from 4 to 6 Jul 2018. Here, the Commercial Eyes Market Access team provides an overview of the meeting agenda, including submissions relating to biosimilars lodged for this meeting. The Commercial … Continue reading
PBAC Meeting Outcomes – March 2018
The March 2018 PBAC Meeting Outcomes were published on 20th April 2018. With 71 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including an additional analysis conducted on oncology submissions which have … Continue reading
PBAC outcomes: a snapshot of 2017
The Commercial Eyes Market Access Team can help you navigate Australia and New Zealand’s sophisticated and mature systems of Health Technology Assessment. Contact us on (03) 9251 0777 to learn more about our PBAC Outcomes Database and let us … Continue reading
Commercial Eyes Recruiting: Senior Market Access Consultant
Commercial Eyes has a great opportunity for a Senior Market Access consultant to join our dynamic Market Access team. Reporting to the Health Economics and Market Access Manager, this senior consulting role offers the successful candidate the opportunity to gain … Continue reading
Contemporary Economic Modelling – State of the Art
The Albert Einstein adage, “Everything should be made as simple as possible, but not simpler.” was the overarching principal that economic modellers should adhere to, communicated in the quarterly workshop session “Contemporary Economic Modelling”, attended by members of Commercial Eyes’ … Continue reading
Commercial Eyes Recruiting: Market Insight Manager
Commercial Eyes has an exciting opportunity for a Market Insight Manager Due to the growth and structural change in the Commercial Eyes business over the last three years, we are hiring a Market Insight Manager on a full time basis, … Continue reading
Innovation in Healthcare: Aligning clinical development and commercial strategies
Innovation is a crucial ingredient to providing breakthroughs in the life sciences sector. From penicillin to the human genome, innovation can generate great leaps in science. On November 30, BioMelbourne Network launched Victoria’s Innovation Week by celebrating the positive advances … Continue reading
